- Supported exchanges /
- TWO /
- 6712.TWO
Ever Supreme Bio Technology Co. Ltd (6712 TWO) stock market data APIs
Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells. Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product; and bone-marrow stem cells (BMSC), used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries. The company was incorporated in 2016 and is based in Taichung, Taiwan.
Ever Supreme Bio Technology Co. Ltd Financial Data Overview
182 | |
182 | |
- | |
182 | |
180.5 | |
164.0059-215 | |
14 682 M | |
29.1667 | |
80 673 K | |
824 M | |
1.34 | |
0.0331 | |
0.281 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Ever Supreme Bio Technology Co. Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 824 M
- EBITDA 421 M
- Earnings Per Share 6.24
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Ever Supreme Bio Technology Co. Ltd Earnings via APIs
- Latest Release 2024-03-15
- EPS/Forecast 1.33
Get Ever Supreme Bio Technology Co. Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: